2BBBullish & Bearish
Fortress Biotech, Inc. (FBIO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 29 out of 100.
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.
Fortress Biotech, Inc.’s current 2BB score is 29 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 10 | Very Low |
| Momentum | 42 | Stable |
| Financial strength | 40 | Weak |
| Quality | 80 | Very Strong |
| Risk | 42 | Moderate |
| CEO | Lindsay Rosenwald |
| Headquarters | Bay Harbor Islands, Florida, United States |
| Founded | 2006 |
| Employees | 78 |
| P/E ratio | 0.95 |
| 52-week range | $1.91 – $4.53 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.2754 | — | $22.01M |
| 2026-08-12 | — | -0.204 | — | $18.67M |
| 2026-05-13 | — | -0.2244 | — | $16.66M |
| 2026-03-31 | -0.01 | 0.1122 | $16.08M | $26.69M |